Toronto Stock Exchange Symbol: DND
MISSISSAUGA, ON, April 15, 2013 /CNW/ - Cipher Pharmaceuticals
Inc. (TSX: DND; OTC: CPHMF) today announced it will host a
conference call for its Q1 2013 financial results and hold its
Annual and Special Meeting of Shareholders on Friday, May 3, 2013.
Q1 2013 CONFERENCE CALL
WHEN: Friday, May 3,
2013 at 8:30AM ET
CONFERENCE CALL/WEBCAST: You can join the call by
dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will
be available through http://www.cipherpharma.com or
http://bit.ly/XUdD6c. An archived replay of the webcast will be
available for 365 days.
ANNUAL AND SPECIAL MEETING OF
SHAREHOLDERS
WHEN: Friday, May 3,
2013 at 11:00AM ET
WHERE: Goodmans LLP, Bay Adelaide Centre, 333
Bay Street, Suite 3400, Toronto,
Ontario
WEBCAST: The meeting will be webcast live. To
access the webcast go to http://www.cipherpharma.com or
http://bit.ly/ZN3zX9. Please connect at least 15 minutes prior to
the start of the meeting to ensure adequate time for any software
download that may be required to join the webcast. An archived
replay of the webcast will be available for 365 days.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing
specialty pharmaceutical company with three commercial products and
a fourth in development. Our product candidates are typically
improved formulations of successful, currently marketed drugs. We
in-license a product, manage the required clinical development and
regulatory approval process, and either out-license it to a
marketing partner, or, in Canada,
we may choose to market the product ourselves. Our core
capabilities are in clinical and regulatory affairs, product
licensing, supply chain management, and marketing and sales. Since
the Company was founded in 2000, we have achieved final regulatory
approval in the U.S. and Canada
for all three of our original products and completed five marketing
partnerships, generating growing licensing revenue.
SOURCE Cipher Pharmaceuticals Inc.